An Open-Label Phase 1 Study to Examine the Effect of Multiple Doses of Rifampin on the Single-Dose Pharmacokinetics of VX 770 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 06 May 2010
At a glance
- Drugs Ivacaftor; Rifampicin
- Indications Bacterial infections; Cystic fibrosis
- Focus Pharmacokinetics
- Sponsors Vertex Pharmaceuticals
- 07 Jan 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 12 Dec 2009 New trial record